Full history for every metric is available with a Kvantra account

Stock profile

Vapotherm, Inc. (VAPO)

Country: United States of AmericaSector: HealthcareIndustry: Medical - DevicesExchange: NYSE

Delisted · last close 19 Sep 2024

Current price
2.17 USD-0.46%
Last close 19 Sep 2024
Benchmarks

Key financial summary

Financials in USD
201820192020202120222023TTM
Total revenue$m4248126113676971
Operating profit$m-39-30
Net profit$m-42-51-56-60-113-58-54
EPS reported$-9.64-8.60
Operating cashflow per share$-4.02-4.02
Capex per share$0.500.50
FCF per share$-4.52-4.52
Free cash flow$m-27-21
Net debt$m97116
Book value equity$m-55-81
Book value per share$-9.17-12.62
Number of sharesm6.046.44
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
201820192020202120222023TTM
Value
P/E TTMx--
P/B LTMx-0.11-0.17
P/S LTMx0.090.19
P/FCF LTMx-0.22-0.65
EV/EBITDA LTMx-3.16-5.10
EV/Sales LTMx1.581.82
Earnings Yield LTM%-963.86%-444.18%
FCF Yield%-451.61%-154.66%
Quality
ROE%105.17%139.34%
ROIC%-64.13%-64.13%
Operating margin%-56.91%-56.91%
Gross margin%41.19%41.19%
FCF/Sales%-39.71%-39.71%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+2.80%+7.49%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-0.24-0.17
Net Debt/EBITDAx-2.99-2.99
EBIT/Net interestx-2.09-2.09
Net debt/market cap%1612.2%852.32%
Net debt/Equityx-1.76-1.42
Gross debt/equityx-2.03-1.51

Company overview

Vapotherm, Inc. is a medical technology company focused on creating and selling its unique high-velocity therapy products. These devices are designed to assist patients of all ages who are experiencing respiratory distress, with sales reaching both domestic and international markets. The company's primary offerings include its "Precision Flow" system lineup, featuring models such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. These innovative systems deliver heated, humidified, and oxygen-enriched air at a high flow rate directly to patients through small-bore nasal interfaces. Beyond its core systems, Vapotherm also supplies a variety of essential accessories. The Vapotherm Transfer Unit enables patients to be moved between hospital areas or walk around while continuing their therapy. A Q50 compressor is available to provide the necessary compressed air for the Precision Flow systems. For medication delivery, the company offers an aerosol aeroneb adaptor, facilitating the provision of ultrasonic aerosolized medication, as well as an aerosol disposable patient circuit designed to streamline both continuous and intermittent aerosol drug administration. Tracheostomy adaptors are also part of their product range. Furthermore, Vapotherm manufactures ProSoft cannulas, engineered for comfortable skin contact, alongside various disposable items, including single-use components and nasal interfaces. Clinicians can also utilize Oxygen Assist Modules, which aid in keeping patient oxygen levels within a desired therapeutic range. The company distributes its medical products predominantly to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.

WebsiteN/A
IndustryMedical - Devices
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 19 Sep 2024

Vapotherm, Inc. (VAPO)

VAPO · NYSE · Healthcare
2.17 USD-0.46%
Benchmarks
Financialsin USD
20222023TTM
About

Vapotherm, Inc. is a medical technology company focused on creating and selling its unique high-velocity therapy products. These devices are designed to assist patients of all ages who are experiencing respiratory distress, with sales reaching both domestic and international markets. The company's primary offerings include its "Precision Flow" system lineup, featuring models such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. These innovative systems deliver heated, humidified, and oxygen-enriched air at a high flow rate directly to patients through small-bore nasal interfaces. Beyond its core systems, Vapotherm also supplies a variety of essential accessories. The Vapotherm Transfer Unit enables patients to be moved between hospital areas or walk around while continuing their therapy. A Q50 compressor is available to provide the necessary compressed air for the Precision Flow systems. For medication delivery, the company offers an aerosol aeroneb adaptor, facilitating the provision of ultrasonic aerosolized medication, as well as an aerosol disposable patient circuit designed to streamline both continuous and intermittent aerosol drug administration. Tracheostomy adaptors are also part of their product range. Furthermore, Vapotherm manufactures ProSoft cannulas, engineered for comfortable skin contact, alongside various disposable items, including single-use components and nasal interfaces. Clinicians can also utilize Oxygen Assist Modules, which aid in keeping patient oxygen levels within a desired therapeutic range. The company distributes its medical products predominantly to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.

IndustryMedical - Devices
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free